Here, 12 patients received unilateral subthalamic rAAV-GAD vector injections, and 10 of 12 patients demonstrated improvement in the Unified Parkinson’s Disease Rating Scale (UPDRS) score after three months of the injection; the improvement persisted for 12 months.122. The gene discussed is GAD1; the disease is Parkinson disease.